Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia

被引：1
|
作者：
Jamy, Omer [1 ]
Diebold, Kendall [1 ]
Davis, Kenneth [2 ]
Bachiashvili, Kimo [1 ]
Rangaraju, Sravanti [1 ]
Vachhani, Pankit [1 ]
Godby, Kelly N. [1 ]
Salzman, Donna [1 ]
Bhatia, Ravi [1 ]
机构：
[1] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 07期
关键词：
D O I：
10.1038/s41409-023-01977-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：823 / 825
页数：3
相关论文
共 50 条
  • [41] EARLY POST-TRANSPLANT IMMUNE DYNAMICS PREDICT RELAPSE RISK IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA
    Sariipek, Nurefsan
    Safina, Ksenia
    Li, Shuqiang
    Lu, Wesley
    Cutler, Corey
    Livak, Kenneth
    Garcia, Jacqueline
    Lindsley, Coleman
    Luskin, Marlise
    Wu, Catherine
    Ritz, Jerome
    Antin, Joseph
    Soiffer, Robert
    Lane, Andrew
    Gooptu, Mahasweta
    van Galen, Peter
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [42] Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
    Zhang, Lijuan
    Chen, Kankan
    Li, Yingying
    Chen, Qiuni
    Shi, Wenting
    Ji, Tingting
    Tao, Hong
    He, Zhengmei
    Wang, Chunling
    Yu, Liang
    HEMATOLOGY, 2023, 28 (01)
  • [43] Patients with TP53-Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective Study
    Sumransub, Nuttavut
    Steinwand, Gabriel K.
    Cordner, Keith
    Lee, Yoonkyu
    Cao, Qing
    Allred, Jeremy
    Bachanova, Veronika
    Juckett, Mark
    Eckfeldt, Craig
    Maakaron, Joseph E.
    Tracy, Sean I.
    Ramesh, Vidhyalakshmi
    Nelson, Andrew C.
    Yohe, Sophia
    Sachs, Zohar
    CANCERS, 2024, 16 (16)
  • [44] TP53-mutated Acute Myeloid Leukemia with Myelodysplasia-Related Changes and Therapy-Related Acute Myeloid Leukemia Have Comparable TP53 Mutational Signature and Clinical Features
    Tashakori, Mehrnoosh
    Tapan, Kadia
    Loghavi, Sanam
    Tang, Zhenya
    Routbort, Mark
    Ravandi-Kashani, Farhad
    Khoury, Joseph
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1027 - 1028
  • [45] Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Badar, Talha
    Atallah, Ehab
    Shallis, Rory
    Saliba, Antoine N.
    Patel, Anand
    Bewersdorf, Jan P.
    Grenet, Justin
    Stahl, Maximilian
    Duvall, Adam
    Burkart, Madelyn
    Palmisiano, Neil
    Bradshaw, Danielle
    Kubiak, Michal
    Dinner, Shira
    Goldberg, Aaron D.
    Abaza, Yasmin
    Murthy, Guru Subramanian Guru
    Kota, Vamsi
    Litzow, Mark R.
    LEUKEMIA, 2023, 37 (04) : 799 - 806
  • [46] Prognostic and Therapeutic Implications of Mutant TP53 Variant Allelic Frequency in Adults with Newly Diagnosed TP53-Mutated Acute Myeloid Leukemia
    Short, Nicholas J.
    Montalban-Bravo, Guillermo
    Hwang, Hyunsoo
    Ning, Jing
    Franquiz, Miguel
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Dinardo, Courtney D.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Takahashi, Koichi
    Konopleva, Marina
    Daver, Naval
    Jabbour, Elias
    Yilmaz, Musa
    Issa, Ghayas C.
    Andreeff, Michael
    Kadia, Tapan M.
    BLOOD, 2020, 136
  • [47] Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Talha Badar
    Ehab Atallah
    Rory Shallis
    Antoine N. Saliba
    Anand Patel
    Jan P. Bewersdorf
    Justin Grenet
    Maximilian Stahl
    Adam Duvall
    Madelyn Burkart
    Neil Palmisiano
    Danielle Bradshaw
    Michal Kubiak
    Shira Dinner
    Aaron D. Goldberg
    Yasmin Abaza
    Guru Subramanian Guru Murthy
    Vamsi Kota
    Mark R. Litzow
    Leukemia, 2023, 37 : 799 - 806
  • [48] Treatment outcomes for newly diagnosed, treatment-naive TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis
    Daver, Naval G. G.
    Iqbal, Shahed
    Renard, Camille
    Chan, Rebecca J. J.
    Hasegawa, Ken
    Hu, Hao
    Tse, Preston
    Yan, Jiajun
    Zoratti, Michael J. J.
    Xie, Feng
    Ramsingh, Giridharan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [49] Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation
    Pasca, Sergiu
    Haldar, Saurav D.
    Ambinder, Alexander
    Webster, Jonathan A.
    Jain, Tania
    Dalton, W. Brian
    Prince, Gabrielle T.
    Ghiaur, Gabriel
    Dezern, Amy E.
    Gojo, Ivana
    Smith, B. Douglas
    Karantanos, Theodoros
    Schulz, Cory
    Stokvis, Kristin
    Levis, Mark J.
    Jones, Richard J.
    Gondek, Lukasz P.
    HAEMATOLOGICA, 2024, 109 (03) : 948 - 952
  • [50] Racial disparities in patients with TP53 mutated acute myeloid leukemia.
    Badar, Talha
    Litzow, Mark Robert
    Shallis, Rory
    Stahl, Maximilian
    Bewersdorf, Jan Philipp
    Saliba, Antoine N.
    Correia, Guilherme Sacchi De Camargo
    Patel, Anand Ashwin
    Abaza, Yasmin
    Murthy, Guru Subramanian Guru
    Duvall, Adam
    Burkart, Madelyn
    Al-Kali, Aref
    Palmisiano, Neil
    Dinner, Shira
    Goldberg, Aaron David
    Atallah, Ehab L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19007 - E19007
12345